Ascendis Slammed After Growth Hormone Drug Faces An Unexpected Challenge

Ascendis Slammed After Growth Hormone Drug Faces An Unexpected Challenge

Submitted by admin on May 12, 2022 - 10:18am
Source: 
Investors Business Daily
News Tags: 
Ascendis Pharma
Skytrofa
earnings
Headline: 
Ascendis Slammed After Growth Hormone Drug Faces An Unexpected Challenge
snippet: 

Biotech stock Ascendis Pharma (ASND) plummeted Thursday after its growth hormone deficiency treatment, Skytrofa, missed first-quarter sales estimates.

Do Not Allow Advertisers to Use My Personal information